2016
DOI: 10.1016/j.ijcard.2015.08.154
|View full text |Cite
|
Sign up to set email alerts
|

Myocardial bridge as a trigger of Kounis syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…11 Traditional coronary risk factors can further worsen the atherosclerotic burden in patients with myocardial bridging. 9 Despite the low coronary risk profile of our patient, the accumulation of mast cells at the proximal segment of the LAD induced myocardial damage. Functional and anatomical alterations of the coronary vessel induced by myocardial bridging can lead to vasospasm at the mid-LAD.…”
Section: Discussionmentioning
confidence: 65%
See 2 more Smart Citations
“…11 Traditional coronary risk factors can further worsen the atherosclerotic burden in patients with myocardial bridging. 9 Despite the low coronary risk profile of our patient, the accumulation of mast cells at the proximal segment of the LAD induced myocardial damage. Functional and anatomical alterations of the coronary vessel induced by myocardial bridging can lead to vasospasm at the mid-LAD.…”
Section: Discussionmentioning
confidence: 65%
“…They are noted to be present in artherosclerotic lesions during acute coronary syndrome triggered by allergic reaction as well as in normal coronary arteries during vasospasms. 9 Cardiac mast cells respond to not only IgE-mediated stimuli but can also be activated by radiocontrast media. They release chymase and renin upon liberation which further activates the renin-angiotensin system and promotes local secretion of noradrenaline with subsequent stimulation of the adrenergic system.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In patients with the type I variant, treatment of allergy alone eliminates symptoms. For type II and III kounis syndrome, antiallergic therapy is as important as revascularization ( 10 ). Vasodilators such as calcium channel blockers and nitrates can be used to eliminate anaphylactogenic vasospasm ( 11 ).…”
Section: Discussionmentioning
confidence: 99%
“…The most frequent triggers for Kounis syndrome are drugs (metamizole [13], beta-lactam antibiotics: ampicillin-sulbactam [13][14][15], penicillin [2], cefuroxime [16][17][18], and other antibiotics, such as fluoroquinolones-levofloxacin [19]), contrast agents (gadolinium derivates [20,21]), insect venoms and snake venoms (Hymenoptera, cobra [22][23][24][25]), certain foods (tuna fish [26]), and proteins present in the natural latex [11]. Additionally, predisposing medical conditions, such as myocardial bridge (MB) [27], and atopic conditions have been described. The exact importance of triggers vs. preexistent pathology in driving Kounis syndrome remains to be established.…”
Section: Introductionmentioning
confidence: 99%